← Back to all trials
Recruiting
NCT05650086
Novel Thermal Imaging Technique for Breast Screening
Conditions: Breast Cancer
Sex: All
Ages: 21 Years – N/A
Healthy volunteers: 1
Enrollment: 700
Sponsor: University of Arizona
Location: United States
Summary
This trial is to study a new breast imaging tool called Thermalytix™.
ThermalytixTM is a new radiation-free, automated breast cancer screening technique that uses Artificial Intelligence (AI) over thermal images.
Thermal images are heat signatures in our body.
This new technique will capture heat signatures in the breast and analyze those images with AI software.
This study will evaluate the performance of ThermalytixTM breast imaging against standard imaging modalities, such as mammography and ultrasound.
Eligibility Criteria
Inclusion Criteria:Be capable of understanding the investigational nature of the study and all pertinent aspects of the studyBe capable of signing and providing written consent in accordance with institutional and federal guidelinesBe willing and able to comply with scheduled visits, treatment plan, and follow up with research staffAge ≥ 21 yearsCohort specific criteriaCohort 1: Be scheduled for biopsyCohort 2: Had a normal screening mammogram within 3 months of study enrollmentCohort 3: Be scheduled for diagnostic mammogramCohort 4: History of breast cancer, s/p lumpectomy and be scheduled for routine mammogramExclusion Criteria:Cohort specific criteriaCohort 1: Previous biopsies in the same or opposite breast within 3 months of study enrollment, prior history of breast cancer, prior history of breast surgeries including implantsCohort 2: prior history of breast surgeries including implantsCohort 3: Already underwent a biopsy in the same or opposite breast within 3 months of study enrollment, prior history of breast cancer, prior history of breast surgeries including implantsCohort 4: surgery <1 year, h/o mastectomy with reconstructionUnable to complete study related procedures
Source: ClinicalTrials.gov (NCT05650086). StuddyBuddy aggregates publicly available trial information.